What Is Wegovy?
Wegovy is a prescription weight management medication designed for adults with obesity or overweight who also have weight-related health risks. Its active ingredient, semaglutide, is a GLP-1 receptor agonist that works by mimicking natural hormones that regulate appetite and food intake. Unlike over-the-counter solutions or fad diets, Wegovy is backed by rigorous clinical trials and real-world patient outcomes.
The Wegovy brand is manufactured by Novo Nordisk—a leader in metabolic and obesity medicine. With its approval in 2021, Wegovy quickly became a cornerstone therapy for evidence-based, physician-guided weight loss.
Who Is Wegovy For?
- Adults with a body mass index (BMI) of 30 or higher (obesity)
- Adults with a BMI of 27 or higher (overweight) plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol
- Patients committed to lifestyle changes—Wegovy is proven most effective alongside healthy diet and physical activity
- Those evaluated and monitored by a qualified healthcare provider
Wegovy is not intended for: individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those with prior serious allergic reactions to semaglutide.
How Does Wegovy Work?
Semaglutide, Wegovy’s active ingredient, mimics Glucagon-Like Peptide-1 (GLP-1)—a hormone that signals fullness and slows gastric emptying. By acting on GLP-1 receptors in the brain, Wegovy reduces appetite, lowers calorie intake, and enhances satiety after meals. This multi-pronged approach makes it distinct from older medications that simply suppress hunger or block fat absorption.
- GLP-1 pathway: Triggers the brain’s own satiety signals, helping patients feel satisfied with less food.
- Blood sugar modulation: Reduces post-meal glucose spikes, supporting metabolic health—especially in those with insulin resistance.
- Gradual dose escalation: Mitigates side effects and allows the body to adapt for better long-term adherence.
Want a deeper dive into GLP-1’s mechanism? Explore our GLP-1 guide for more.
Wegovy Dosage: What To Expect
Wegovy is typically started at a low dose and titrated up every four weeks to minimize side effects. The prescribed dosing schedule is as follows:
- Start: 0.25 mg once weekly for 4 weeks
- Increase: 0.5 mg once weekly for weeks 5-8
- Gradual escalation through 1 mg and 1.7 mg as tolerated
- Maintenance: 2.4 mg once weekly (full therapeutic dose)
Each injection is delivered using a prefilled, disposable pen device—no vials or syringes needed. For visuals and instructions, see the Wegovy Dosage Guide.
If you miss a dose and your next scheduled injection is more than two days away, take the missed dose as soon as possible. If it's closer, skip and resume your regular schedule. Never double up.
Wegovy Side Effects & Safety
Most people tolerate Wegovy well, but side effects are possible—especially during dose increases. The most common are mild and resolve with time:
- Nausea (in up to 44% of patients)
- Diarrhea
- Vomiting
- Constipation
- Abdominal discomfort
Serious side effects are uncommon but can include pancreatitis, gallbladder disease, and (rarely) thyroid tumors. Seek immediate medical attention for severe abdominal pain or persistent vomiting.
For an in-depth breakdown, visit our Wegovy Side Effects page.
What Results Can I Expect With Wegovy?
In pivotal clinical trials, adults taking Wegovy lost an average of 12-15% of their starting weight over 68 weeks—substantially higher than with placebo or lifestyle changes alone. Many patients report improvements in energy, blood pressure, and metabolic markers within months. However, results vary, and success depends on continued lifestyle change and consistent dosing.
Here’s what real patients and published data reveal:
- Weight loss often begins within the first 4 weeks
- Maximal weight loss is typically achieved after 6-12 months
- Some experience weight plateaus—consistent injection schedule and dietary adjustment can help break through
- Stopping Wegovy may lead to regaining some weight, further highlighting the value of lifelong habits
For more on clinical outcomes, see our Wegovy Weight Loss resource.
Comparing Wegovy to Other Obesity Medications
Wegovy stands apart for its efficacy and tolerability, but it’s not the only option. Alternatives include:
- Semaglutide in lower-dose forms (as Ozempic, for type 2 diabetes)
- Liraglutide (Saxenda)
- Bupropion/naltrexone (Contrave)
- Phentermine/topiramate (Qsymia)
Each medication comes with unique pros, cons, and eligibility requirements. To determine which is best for your goals, discuss options with your healthcare provider and review our Obesity Medication Overview.
How Do I Start Wegovy?
- Consult your primary care provider or obesity medicine specialist for an evaluation.
- Undergo baseline labs and medical review to confirm suitability.
- Review dosing schedule, injection technique (see our Weekly Injection Guide), and insurance coverage.
- Begin therapy with ongoing check-ins for dose titration and monitoring.
Remember, Wegovy is not a quick fix—it’s a structured, medical approach to lifelong weight health.